Abeona Therapeutics' chief medical officer steps down; replacement named
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Insight Weekly: Renewables lead capacity additions; bank mergers of equals up; nickel IPOs surge
Insight Weekly: Utilities face headwinds; S&P 500 dividend hikes likely; dollar poised for rally
Abeona Therapeutics Inc. said Juan Ruiz will step down as chief medical officer and assume the role of head of European medical affairs.
The Dallas-based biopharmaceutical company appointed João Siffert as its head of research and development and chief medical officer.
Previously, Siffert served on the board of directors of gene therapy developer AveXis Inc., which was acquired by Swiss drugmaker Novartis AG.
